Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zimmer Told to Pay Stryker $70 Million for Surgical Tool Patents
Bloomberg
Tuesday, February 5, 2013 - 10:22pm
tags:
Zimmer, Stryker, patent, surgical
Teleflex Signs New Agreement with Novation for Weck Vista™ Access Line
Yahoo/BusinessWire
Tuesday, February 5, 2013 - 10:14pm
tags:
Teleflex Medical, contract, Novation, devices
Covidien Announces Continued Relationship with NYSE Euronext
Yahoo/BusinessWire
Tuesday, February 5, 2013 - 10:14pm
tags:
Covidien, Neuronext, contract, devices
CASMED Announces Recent Publication of Study Using FORE-SIGHT Cerebral Tissue Oximetry in the Post-Surgical ICU
Yahoo/GlobeNewswire
Tuesday, February 5, 2013 - 10:13pm
tags:
CASMED, oximetry, devices
The Cooper Companies Announces Release Date for First Quarter 2013
Yahoo/BusinessWire
Tuesday, February 5, 2013 - 10:12pm
tags:
Cooper Companies, earnings, devices
The Cooper Companies Announces Release Date for First Quarter 2013
Yahoo/BusinessWire
Tuesday, February 5, 2013 - 10:12pm
tags:
Cooper Companies, earnings, devices
Thoratec® Reports Fourth Quarter And Full Year Fiscal 2012 Financial Results
Yahoo/PRNewswire
Tuesday, February 5, 2013 - 10:11pm
tags:
Thoratec, earnings, devices
Conceptus(R) Reports Fourth Quarter Financial Results and Introduces 2013 Financial Guidance
Yahoo/GlobeNewswire
Tuesday, February 5, 2013 - 10:10pm
tags:
Conceptus, earnings
Vascular Solutions Reports Record Fourth Quarter Results
Yahoo/GlobeNewswire
Tuesday, February 5, 2013 - 10:10pm
tags:
Vascular Solutions, earnings
Kips Bay Medical Announces the First U.S. Implant in the eMESH I Clinical Feasibility Trial
Yahoo/BusinessWire
Tuesday, February 5, 2013 - 10:09pm
tags:
Kips Bay Medical, Implant, eMesh, clinical trials
Layoffs, check. Now, on to hiring--and talent's scarce
Fierce Pharma
Tuesday, February 5, 2013 - 6:13pm
tags:
layoffs, hirings
Allergan Seeks to Sell Lap-Band and Obesity Unit By June
Bloomberg
Tuesday, February 5, 2013 - 6:12pm
tags:
Allergan, Lap-Band, obesity, M&A
Bright Horizons For Dendreon
Seeking Alpha
Tuesday, February 5, 2013 - 6:11pm
tags:
Dendreon
Not Working Out So Well At Merck?
Seeking Alpha
Tuesday, February 5, 2013 - 6:10pm
tags:
Merck, Vytorin
U.S. Senate to mull ban on 'pay for delay' pharmaceutical deals
Reuters
Tuesday, February 5, 2013 - 6:09pm
tags:
pay-for-delay
Glaxo Clashes With PhRMA Over Data Disclosure
Pharmalot
Tuesday, February 5, 2013 - 11:15am
tags:
GSK, PhRMA
Forbes Healthcare Summit: Fixing Drug Discovery Comment Now Follow Comments
Forbes
Tuesday, February 5, 2013 - 11:14am
tags:
drug discovery
Hemispherx's Chronic Fatigue Drug Rejected by FDA
Minyanville
Tuesday, February 5, 2013 - 11:02am
tags:
Hemispherx Biopharma, FDA, chronic fatigue syndrome, Ampligen
Forbes Health Summit: How Patient Groups Are Changing Biotech
Forbes
Tuesday, February 5, 2013 - 10:59am
tags:
biotech, patients
Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product
Yahoo
Tuesday, February 5, 2013 - 10:58am
tags:
FDA, Warner Chilcott, ulcerative colitis, Delzicol

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.